A drug with the SMILES Cc1cc(C(C)(C)C)cc(C)c1Cn1c2[n+](c3ccc(C(F)(F)F)cc31)CCCCC2.[Cl-] has a hERG inhibition at a concentration of 10uM of -55.435%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cc(C(C)(C)C)cc(C)c1Cn1c2[n+](c3ccc(C(F)(F)F)cc31)CCCCC2.[Cl-]
Cc1cc(C(C)(C)C)cc(C)c1Cn1c2[n+](c3ccc(C(F)(F)F)cc31)CCCCC2.[Cl-]
5-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-3-(trifluoromethyl)-7,8,9,10-tetrahydro-6H-azepino[1,2-a]benzimidazol-11-ium;chloride